Recurrent uveitis under golimumab treatment in a patient diagnosed with axial spondyloarthritis: Is it a paradoxical effect?
Alper Mengi
Turkish Journal of Physical Medicine and Rehabilitation · 2019-05
Abstract
Anti-tumor necrosis factor drugs are highly effective in the treatment of spondyloarthropathies. In recent years, there have been reports of paradoxical effects with the use of these drugs. Herein, we report the first case of axial spondyloarthropathy in whom recurrent attacks of panuveitis paradoxically developed under golimumab treatment in the light of literature data.
MeSH terms
- Golimumab
- Spondyloarthropathy
- Medicine
- Spondylarthropathies
- Uveitis
- Axial spondyloarthritis
- HLA-B27
- Ankylosing spondylitis
- Spondylarthritis
- Paradoxical reaction
- Dermatology
- Adalimumab